BUY Jio Platforms Limited — Motilal Oswal
byMotilal OswalHorizon: NA (inferred 1 year)1 Nov 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
After bumper IPO listing, Jio Platforms shares jump 3% post strong Q2 results | Should you buy, sell or hold?
NewsLivemint·2 Nov · 5d ago
Jio Platforms' shares climb over 3% post Q2 earnings
NewsHbl·2 Nov · 5d ago
Jio Platforms shares climb over 3% after Q2 PAT rises 14% YoY to Rs 8,389 crore. Buy, sell or hold?
NewsEt-Markets·2 Nov · 5d ago
Jio Platforms shares rise after first post-listing results; subscriber additions remain healthy
NewsCnbc-Tv18·2 Nov · 5d ago
Jio Platforms profit zooms 14% on healthy user mix, digital play
NewsEt-Markets·31 Oct · 1w ago
Please find attached Unaudited Financial Results (Consolidated and Standalone) for the quarter and half year ended September 30, 2026.
BSE · Board Meeting·30 Oct · 1w ago
Jio Platforms first Q2 results after bumper listing: check date; Reliance firm’s earnings in focus; key numbers to watch
NewsLivemint·29 Oct · 1w ago
Jio debuts on D-Street: India’s biggest IPOs delivered negative returns over one month after listing. Will Jio break the curse?
NewsEt-Markets·28 Oct · 1w ago
Jio Platforms Shares Debut At Over 21% Premium. Should Investors Buy, Sell Or Hold?
NewsNdtv-Profit·28 Oct · 1w ago
Jio Platforms Has The Scale. Can Broadband, Digital Services And Cash Flow Unlock Its Next Growth Phase?
NewsNdtv-Profit·28 Oct · 1w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Jio Platforms
All analyst calls on Jio PlatformsMore from Motilal Oswal
- BUY Zydus Lifesciences6 Nov 2026 · ~1 year · target ₹1,480 · Active
- BUY Neogen Chemicals6 Nov 2026 · ~1 year · target ₹2,765 · Active
- BUY BSE5 Nov 2026 · ~1 year · target ₹4,200 · Active
- BUY Apollo Hospitals Enterprise5 Nov 2026 · ~1 year · target ₹10,400 · Active
- BUY Bharat Electronics3 Nov 2026 · ~1 year · target ₹540 · Active

